Ausgabe 6/2013
Inhalt (15 Artikel)
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide
Luis Sanchez-Perez, Bryan D. Choi, Elizabeth A. Reap, Elias J. Sayour, Pamela Norberg, Robert J. Schmittling, Gerald E. Archer, James E. Herndon 2nd, Duane A. Mitchell, Amy B. Heimberger, Darell D. Bigner, John H. Sampson
Impaired migration of IgA-secreting cells to colon adenocarcinomas
Rangarajan V. Muthuswamy, Patrik Sundström, Lars Börjesson, Bengt Gustavsson, Marianne Quiding-Järbrink
Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response
Holger N. Lode, Manuela Schmidt, Diana Seidel, Nicole Huebener, Diana Brackrock, Matthias Bleeke, Daniel Reker, Sven Brandt, Hans-Peter Mueller, Christiane Helm, Nikolai Siebert
Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models
Sandip Pravin Patel, Andrew Bristol, Olga Saric, Xue-Ping Wang, Alex Dubeykovskiy, Philip M. Arlen, Michael A. Morse
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme
Anna Maria Di Giacomo, Luana Calabrò, Riccardo Danielli, Ester Fonsatti, Erica Bertocci, Isabella Pesce, Carolina Fazio, Ornella Cutaia, Diana Giannarelli, Clelia Miracco, Maurizio Biagioli, Maresa Altomonte, Michele Maio
The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer
Hideya Onishi, Takashi Morisaki, Akifumi Kiyota, Norihiro Koya, Hiroto Tanaka, Masayo Umebayashi, Mitsuo Katano
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Laura Tomasello, Simone Negrini, Francesca Kalli, Florinda Battaglia, Francesca Ferrera, Stefania Sciallero, Giuseppe Murdaca, Maurizio Setti, Alberto Sobrero, Francesco Boccardo, Giuseppe Cittadini, Francesco Puppo, Domenico Criscuolo, Giorgio Carmignani, Francesco Indiveri, Gilberto Filaci
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial
Christoph Domschke, Yingzi Ge, Isa Bernhardt, Sarah Schott, Sophia Keim, Simone Juenger, Mariana Bucur, Luisa Mayer, Maria Blumenstein, Joachim Rom, Joerg Heil, Christof Sohn, Andreas Schneeweiss, Philipp Beckhove, Florian Schuetz
Preexisting antitumor immunity augments the antitumor effects of chemotherapy
Lingbing Zhang, Dongdong Feng, Lynda X. Yu, Kangla Tsung, Jeffrey A. Norton
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin
Shivani Srivastava, David Pelloso, Hailin Feng, Larry Voiles, David Lewis, Zdenka Haskova, Margaret Whitacre, Stephen Trulli, Yi-Jiun Chen, John Toso, Zdenka L. Jonak, Hua-Chen Chang, Michael J. Robertson
Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
Tomar Ghansah, Nasreen Vohra, Kathleen Kinney, Amy Weber, Krithika Kodumudi, Gregory Springett, Amod A. Sarnaik, Shari Pilon-Thomas
Antibody–peptide–MHC fusion conjugates target non-cognate T cells to kill tumour cells
Ben C. King, Angela D. Hamblin, Philip M. Savage, Leon R. Douglas, Ted H. Hansen, Ruth R. French, Peter W. M. Johnson, Martin J. Glennie
Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer
Daniel Mazal, Richard Lo-Man, Sylvie Bay, Otto Pritsch, Edith Dériaud, Christelle Ganneau, Andrea Medeiros, Luis Ubillos, Gonzalo Obal, Nora Berois, Mariela Bollati-Fogolin, Claude Leclerc, Eduardo Osinaga
Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy
Guohong Song, Xiaoli Wang, Jun Jia, Yanhua Yuan, Fengling Wan, Xinna Zhou, Huabing Yang, Jun Ren, Jiezhun Gu, Herbert Kim Lyerly
Highlights of melanoma research presented at the 48th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, June 1–5, 2012
Dorothee Herlyn, Clemens Krepler